Elicera Therapeutics AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2021-07-07 | Elicera Therapeutics AB | Di Yu | Deputy Member of the Board of Directors | Return of loan increase | 2 583 334 | 0 | SEK | 0 | 2021-07-06 |
| 2021-07-08 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Return of loan increase | 2 583 333 | 0 | SEK | 0 | 2021-07-07 |
| 2021-07-10 | Elicera Therapeutics AB | Magnus Essand | Chairman of the Board of Directors | Return of loan increase | 2 583 333 | 0 | SEK | 0 | 2021-07-06 |
| 2024-03-08 | Elicera Therapeutics AB | Rolf Ingvar Lennart Karlsson | Chief Financial Officer (CFO) | Subscription | 4 800 | 16,2 | SEK | 77 760 | 2024-03-07 |
| 2024-03-08 | Elicera Therapeutics AB | Di Yu | Deputy Member of the Board of Directors | Subscription | 12 345 | 16,2 | SEK | 199 989 | 2024-03-07 |
| 2024-03-08 | Elicera Therapeutics AB | Magnus Essand | Chairman of the Board of Directors | Subscription | 6 173 | 16,2 | SEK | 100 002,6 | 2024-03-07 |
| 2024-03-09 | Elicera Therapeutics AB | Jan Zetterberg | Member of the Board of Directors | Subscription | 4 300 | 16,2 | SEK | 69 660 | 2024-03-07 |
| 2024-03-09 | Elicera Therapeutics AB | Jan Zetterberg | Member of the Board of Directors | Subscription | 10 000 | 16,2 | SEK | 162 000 | 2024-03-07 |
| 2024-03-09 | Elicera Therapeutics AB | Christina Herder | Member of the Board of Directors | Subscription | 3 100 | 16,2 | SEK | 50 220 | 2024-03-07 |
| 2024-03-09 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Subscription | 21 700 | 16,2 | SEK | 351 540 | 2024-03-07 |
| 2024-03-09 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 31 000 | 0,005 | SEK | 158,1 | 2024-03-03 |
| 2024-03-09 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 64 500 | 0,018 | SEK | 1 180,35 | 2024-02-25 |
| 2024-03-09 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Disposal | 1 687 000 | 0,002 | SEK | 2 682,33 | 2024-03-03 |
| 2024-03-09 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Disposal | 500 000 | 0,002 | SEK | 1 200 | 2024-02-29 |
| 2024-03-10 | Elicera Therapeutics AB | Margareth Jorvid | Member of the Board of Directors | Subscription | 3 100 | 16,2 | SEK | 50 220 | 2024-03-07 |
| 2024-03-11 | Elicera Therapeutics AB | Agneta Edberg | Chairman of the Board of Directors | Subscription | 4 518 | 16,2 | SEK | 73 191,6 | 2024-03-07 |
| 2024-03-21 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 2 687 000 | 1,28 | SEK | 3 439 360 | 2024-03-19 |
| 2024-03-21 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Disposal | 2 687 000 | 1,28 | SEK | 3 439 360 | 2024-03-19 |
| 2024-04-26 | Elicera Therapeutics AB | Jamal El Mosleh | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 50 000 | 1 | SEK | 50 000 | 2024-04-24 |
| 2024-05-15 | Elicera Therapeutics AB | Magnus Essand | Member of the Board of Directors | Loan granted | 280 000 | 0,94 | SEK | 263 200 | 2024-05-13 |